Absence ofEGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer
Open Access
- 28 September 2004
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 113 (3), 510-511
- https://doi.org/10.1002/ijc.20591
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Epidermal growth factor receptor: mechanisms of activation and signallingExperimental Cell Research, 2003
- ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft modelBritish Journal of Cancer, 2002